Skip to Content

TEVA 3171 (Clindamycin Hydrochloride 150 mg)

Pill with imprint TEVA 3171 is Red / Blue, Capsule-shape and has been identified as Clindamycin Hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA.

Clindamycin is used in the treatment of bacterial endocarditis prevention; bacteremia; aspiration pneumonia; babesiosis; bacterial infection and belongs to the drug class lincomycin derivatives. There is no proven risk in humans during pregnancy. Clindamycin 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 3171

Clindamycin hydrochloride 150 mg TEVA 3171
Clindamycin hydrochloride 150 mg TEVA 3171
Clindamycin hydrochloride 150 mg TEVA 3171

Clindamycin Hydrochloride

Imprint
TEVA 3171
Strength
150 mg
Color
Red / Blue
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Lincomycin derivatives
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-3171

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.